The global clinical perinatal software market is anticipated to reach a substantial size of USD 303.9 million by the year 2030, demonstrating a robust compound annual growth rate (CAGR) of 10.3% from 2025 to 2030. A significant factor propelling this market growth is the increasing number of stillbirth cases reported globally, highlighting the critical need for advanced monitoring and management solutions during the perinatal period.

The integrated software product segment held the largest share of the market revenue in 2024, indicating a strong preference for comprehensive solutions within the healthcare industry. The increasing demand for seamless workflow integration among medical professionals is expected to be a key driver for the continued growth of this segment in the forthcoming years. Furthermore, ongoing technological advancements in software capabilities and the growing adoption of these integrated systems within healthcare settings are factors projected to continue fueling the segment's expansion throughout the forecast period.

In terms of application, fetal monitoring data services accounted for the largest revenue share in 2024. These vital services provide accurate and comprehensive monitoring of both the fetal heartbeat and uterine contractions, crucial indicators of fetal well-being. The advent of mobile fetal monitoring solutions allows patients to remotely access this critical data, enabling continuous tracking of fetal development. This accessibility and convenience are projected to positively influence the growth of this application segment during the forecast period.

Supportive government initiatives aimed at improving and maintaining maternal health are playing a significant role in increasing the adoption of clinical perinatal software across healthcare facilities. Moreover, the broader adoption and implementation of healthcare IT solutions, such as advanced monitoring systems in clinics, hospitals, and surgical centers, have demonstrably increased the efficiency of healthcare workflows and reduced overall healthcare expenditure, thereby further propelling the growth of the clinical perinatal software market.

Industry players within this market are actively undertaking initiatives focused on the development of new software solutions that incorporate enhanced data security features, thus contributing to further market growth and user confidence. For instance, in May 2018, Myriad Genetics strategically acquired Counsyl to strengthen and expand its portfolio in the area of noninvasive prenatal screening, demonstrating the industry's commitment to innovation and comprehensive perinatal care solutions.

Curious about the Clinical Perinatal Software Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends. 

Key highlights from the Clinical Perinatal Software Market Report include:

• Based on the product type, the integrated segment held the largest revenue share of 80.0% in 2024. This dominance is attributed to the increasing adoption of these comprehensive software solutions across various healthcare providers and clinics, highlighting the value of unified platforms in perinatal care.

• Regarding the deployment model, the on-premise segment accounted for the largest revenue share, exceeding 70.8% in 2024. This preference is primarily due to the perceived enhanced data security and ease of direct access associated with on-premise software installations within healthcare institutions.

• In terms of application, workflow management software is anticipated to exhibit the fastest CAGR over the forecast period. This rapid growth is driven by the increasing recognition of workflow management tools in enhancing productivity and their growing adoption across perinatal care settings.

• Based on the end-use segment, hospitals and clinics dominated the market for clinical perinatal software in terms of revenue share in 2019. This dominance is attributed to the presence of advanced technological infrastructure and a higher patient footfall in these healthcare settings, necessitating robust perinatal software solutions.

• The Asia Pacific region is expected to exhibit the fastest CAGR over the forecast period. This rapid growth can be attributed to factors such as an increase in disposable income within the region and supportive government initiatives focused on improving maternal and child health outcomes.

Order a free sample PDF of the Clinical Perinatal Software Market Intelligence Study, published by Grand View Research.